AALL1931 - An Open-Label, Multicenter Study of RC-P in Patients with Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) Following Hypersensitivity to E. Coll-Derived Asparaginases

Grant

Date/time Interval

  • December 19, 2019 - December 18, 2024

    • Awarded By

    Total Award Amount

  • 252500.00

    • Direct Costs

  • 194233.00

    • Sponsor Award Id

    • Contributor

  • Aman Wadhwa   Investigator  
  • Ana Galtarossa Xavier   Investigator  
  • Julie Wolfson-Stockman M.D.   Investigator  
  • Matthew Kutny M.D.   Principal Investigator  
  • Wayne Liang   Investigator